Outlook Therapeutics, Inc.
OTLK· Nasdaq
OTLKOutlook Therapeutics, Inc.
Filed Dec 29, 2016 · 10-K · 90 days after period end · 0001571049-16-020882
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|
| Revenue | $494.89K | — |
| Net Income | -$10.57M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Outlook Therapeutics, Inc. · CIK 1649989 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Dec 29, 2016 · 90 d after period end
